Roberto Nussenzveig

3.0k total citations
86 papers, 2.0k citations indexed

About

Roberto Nussenzveig is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Genetics. According to data from OpenAlex, Roberto Nussenzveig has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 29 papers in Cancer Research and 19 papers in Genetics. Recurrent topics in Roberto Nussenzveig's work include Prostate Cancer Treatment and Research (40 papers), Cancer Genomics and Diagnostics (15 papers) and Erythrocyte Function and Pathophysiology (14 papers). Roberto Nussenzveig is often cited by papers focused on Prostate Cancer Treatment and Research (40 papers), Cancer Genomics and Diagnostics (15 papers) and Erythrocyte Function and Pathophysiology (14 papers). Roberto Nussenzveig collaborates with scholars based in United States, Canada and Czechia. Roberto Nussenzveig's co-authors include José M. C. Ribeiro, Donald E. Champagne, Neeraj Agarwal, Josef T. Prchal, F. Ann Walker, Umang Swami, Taylor Ryan McFarland, Archana M. Agarwal, Amos Gaikwad and Hassan M. Yaish and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Roberto Nussenzveig

85 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Nussenzveig United States	24	626	625	412	306	303	86	2.0k
M. Cristine Charlesworth United States	31	500 0.8×	1.5k 2.4×	218 0.5×	162 0.5×	153 0.5×	66	3.1k
Isamu Hayata Japan	30	416 0.7×	843 1.3×	247 0.6×	74 0.2×	267 0.9×	112	2.4k
Yves Courty France	24	247 0.4×	549 0.9×	379 0.9×	93 0.3×	288 1.0×	66	1.4k
Linda M. Griffith United States	25	192 0.3×	467 0.7×	233 0.6×	171 0.6×	366 1.2×	41	2.4k
Vı́ctor Quesada Spain	26	125 0.2×	1.8k 2.9×	291 0.7×	196 0.6×	669 2.2×	58	2.9k
Mark Plumb United Kingdom	28	159 0.3×	1.8k 2.9×	109 0.3×	146 0.5×	366 1.2×	65	2.6k
Sandra Offner Switzerland	25	145 0.2×	2.7k 4.3×	459 1.1×	215 0.7×	600 2.0×	37	4.5k
Kevin P. Williams United States	32	120 0.2×	3.1k 5.0×	266 0.6×	71 0.2×	579 1.9×	78	3.9k
Andrew P. Laudano United States	18	430 0.7×	1.6k 2.5×	48 0.1×	128 0.4×	203 0.7×	19	2.3k
Camila O. dos Santos United States	20	89 0.1×	2.2k 3.5×	213 0.5×	163 0.5×	349 1.2×	42	3.0k

Countries citing papers authored by Roberto Nussenzveig

Since Specialization

Citations

This map shows the geographic impact of Roberto Nussenzveig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Nussenzveig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Nussenzveig more than expected).

Fields of papers citing papers by Roberto Nussenzveig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Nussenzveig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Nussenzveig. The network helps show where Roberto Nussenzveig may publish in the future.

Co-authorship network of co-authors of Roberto Nussenzveig

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Nussenzveig. A scholar is included among the top collaborators of Roberto Nussenzveig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Nussenzveig. Roberto Nussenzveig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, Vinay Mathew, Georges Gebrael, Nicolas Sayegh, et al.. (2024). Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI. JCO Precision Oncology. 8(8). e2300574–e2300574. 1 indexed citations

Thomas, Vinay Mathew, Georges Gebrael, Nicolas Sayegh, et al.. (2023). 1800P Differential tumor gene-expression profiling of patients (pts) with de-novo metastatic castration-sensitive prostate cancer (dn-mCSPC) versus (vs.) mCSPC relapsing after prior localized therapy (PLT-mCSPC). Annals of Oncology. 34. S972–S973. 1 indexed citations

Swami, Umang, Ryon P. Graf, Roberto Nussenzveig, et al.. (2022). SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical Cancer Research. 28(22). 4917–4925. 40 indexed citations

McFarland, Taylor Ryan, Vinay Mathew Thomas, Roberto Nussenzveig, et al.. (2022). Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting. Biomedicines. 10(12). 3170–3170. 2 indexed citations

Swami, Umang, Nicolas Sayegh, Yeonjung Jo, et al.. (2022). External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer. Molecular Cancer Therapeutics. 21(12). 1857–1861. 5 indexed citations

Sayegh, Nicolas, Nishita Tripathi, Roberto Nussenzveig, et al.. (2022). Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis–Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer Setting. European Urology Focus. 9(1). 106–109. 4 indexed citations

Tripathi, Nishita, Yeonjung Jo, Abhishek Tripathi, et al.. (2022). Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 40(11). 493.e1–493.e7. 4 indexed citations

Lin, Edwin, Andrew W. Hahn, Roberto Nussenzveig, et al.. (2021). Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform. The Oncologist. 26(9). 751–760. 11 indexed citations

Agarwal, Neeraj, Roberto Nussenzveig, Andrew W. Hahn, et al.. (2020). Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer. Clinical Cancer Research. 26(9). 2104–2110. 16 indexed citations

10.

Sonpavde, Guru, Neeraj Agarwal, Gregory R. Pond, et al.. (2019). Circulating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancer. Cancer. 125(9). 1459–1469. 41 indexed citations

11.

Hahn, Andrew W., David D. Stenehjem, Roberto Nussenzveig, et al.. (2019). Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time. Cancer Treatment and Research Communications. 19. 100120–100120. 13 indexed citations

12.

Hahn, Andrew W., Roberto Nussenzveig, Benjamin L. Maughan, & Neeraj Agarwal. (2019). Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses. 3(1). 7–13. 2 indexed citations

13.

Hahn, Andrew W., David Gill, Roberto Nussenzveig, et al.. (2018). Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC). Molecular Cancer Therapeutics. 18(3). 726–729. 9 indexed citations

14.

Gill, David, Andrew W. Hahn, Eric D. Johnson, et al.. (2017). Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. 16(1). e169–e172. 7 indexed citations

15.

Nussenzveig, Roberto, Robert D. Christensen, Josef T. Prchal, Hassan M. Yaish, & Archana M. Agarwal. (2014). Novel α-Spectrin Mutation in Trans with α-SpectrinLEPRA Causing Severe Neonatal Jaundice from Hereditary Spherocytosis. Neonatology. 106(4). 355–357. 16 indexed citations

16.

Christensen, Robert D., Roberto Nussenzveig, N. Scott Reading, et al.. (2013). Variations in Both α-Spectrin (SPTA1) and β-Spectrin (SPTB) in a Neonate with Prolonged Jaundice in a Family where Nine Individuals Had Hereditary Elliptocytosis. Neonatology. 105(1). 1–4. 17 indexed citations

17.

Lin, Pei, Rajyalakshmi Luthra, Roberto Nussenzveig, & L. Jeffrey Medeiros. (2010). JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome. Human Pathology. 41(5). 758–762. 3 indexed citations

18.

Nussenzveig, Roberto & Josef T. Prchal. (2008). Monoallelic Gene Expression in Health and Disease. The Hematologist. 5(1). 1 indexed citations

19.

Gaikwad, Amos, et al.. (2007). In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 allele. Experimental Hematology. 35(4). 587–595. 32 indexed citations

20.

Nussenzveig, Roberto, Sabina Świerczek, Jaroslav Jelı́nek, et al.. (2006). Polycythemia vera is not initiated by JAK2 mutation. Experimental Hematology. 35(1). 32.e1–32.e9. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact